Abstract:The frequency and distribution of genetic mutations that cause deafness differ significantly according to ethnic group and region. Zhejiang is a province in the southeast of China, with an exceptional racial composition of the population caused by mass migration in ancient China. The purpose of the present study was to investigate the prevalence and spectrum of gap junction-beta 2 (GJB2), solute carrier family 26 (anion exchanger) member 4 (SLC26A4) and GJB3 mutations in patients with autosomal recessive non-syndromic hearing loss (ARNHL) in this area. A total of 176 unrelated pediatric patients with ARNHL were enrolled in the study. A genomic DNA sample was extracted from the peripheral blood. Polymerase chain reaction was employed, and the products were sequenced to screen for mutations in GJB2. In addition, a SNaPshot sequencing method was utilized to detect four hotspot mutations in SLC26A4 (IVS7-2A>G and c.2168A>G) and GJB3 (c.538C>T and c.547G>A). All patients were subjected to a temporal bone computed tomography scan to identify enlarged vestibular aqueducts (EVA). In total, 14 different mutations, including two new mutations (p.W44L and p.D66N) of GJB2, were detected. The most common pathogenic mutation of GJB2 was c.235delC (15.1%), followed by c.176_191del16 (1.7%), c.299_300delAT (1.7%), c.508_511dup (0.85%) and c.35delG (0.28%) of the total alleles. Mutation analysis of SLC26A4 demonstrated that 13.6% (24/176) of patients carried at least one mutant allele. The patients with EVA (84.2%) had SLC26A4 mutations, and 31% had homozygous mutations. Only one patient carried a heterozygous mutation of GJB3 (c.538C>T). Compared with the other regions of China, in the present population cohort, the prevalence and spectrum of mutations in GJB2 was unique, and in patients with EVA the frequency of a homozygous mutation in SLC26A4 was significantly lower. These findings may be of benefit in genetic counseling and risk assessment for families from this area of China.

A novel genotyping technique for discriminating LVAS-associated high-frequency variants in SLC26A4 gene

A Pathogenesis Analysis of SLC26A4 Gene Mutations in 3 Families Associated with Large Vestibular Aqueduct Syndrome

Application of DNA Microarray and Sequencing in Genetic Diagnosis of Enlarged Vestibular Aqueduct Syndrome

Exonic Deletions and Deep Intronic Variants of the SLC26A4 Gene Contribute to the Genetic Diagnosis of Unsolved Patients With Enlarged Vestibular Aqueduct

A New Genetic Diagnostic for Enlarged Vestibular Aqueduct Based on Next-Generation Sequencing

Identification of a Likely Pathogenic Structural Variation in the LAMA1 Gene by Bionano Optical Mapping.

Identification of a Novel Mutation in SLC26A4 Gene in a Chinese Family with Enlarged Vestibular Aqueduct Syndrome.

Analysis of SLC26A4 gene mutations in 4 families associated with large vestibular aqueduct syndrome

Identification of a Novel Mutation of SLC26A4 Gene with Enlarged Vestibular Aqueduct Syndrome

Genetic Testing for the Enlarged Vestibular Aqueduct Syndrome and Mutation Analysis of the SLC26A4 Gene

A Novel Compound Heterozygous Mutation of SLC26A4 in Two Chinese Families with Nonsyndromic Hearing Loss and Enlarged Vestibular Aqueducts

The Incidence and Pathogenic Correlation of SLC26A4 Mono-allelic Mutations in Deaf Patients with Enlarged Vestibular Aqueduct

Molecular Diagnosis of SLC26A4,FOXI1 and KCNJ10 Gene in 35 Shanghai Probands with Non-Syndromic Hearing Loss Associated with Enlarged Vestibular Aqueduct

Validating the splicing effect of rare variants in the SLC26A4 gene using minigene assay

Analysis of SLC26 A4 gene mutations in 5 families associated with enlarge vestibular aqueduct syndrome

Compound heterozygous mutations of SLC26A4 in 4 Chinese families with enlarged vestibular aqueduct.

Identification of two novel mutations, c.232T>C and c.2006A>T, in SLC26A4 in a Chinese family associated with enlarged vestibular aqueduct

Phenotypic Analyses and Mutation Screening of the SLC26A4 and FOXI1 Genes in 101 Taiwanese Families with Bilateral Nonsyndromic Enlarged Vestibular Aqueduct (DFNB4) or Pendred Syndrome

Prevalence and range of GJB2 and SLC26A4 mutations in patients with autosomal recessive non‑syndromic hearing loss.

Molecular Epidemiology and Functional Assessment of Novel Allelic Variants of SLC26A4 in Non-Syndromic Hearing Loss Patients with Enlarged Vestibular Aqueduct in China

Validation and Analysis of Goldengate High-Throughput Deafness Gene Chip in Detecting the Patients with Enlarged Vestibular Aqueduct Syndrome